We also identified three families with variants in TET2, an epigenetic modifier that is recurrently mutated in sporadic AML and clonal hematopoiesis of indeterminate potential (CHIP), but whose germline variants may constitute a predisposing factor for myeloid neoplasm53. The gene discussed is TET2; the disease is acute myeloid leukemia.